Content
02/27/2025
Montreal Canada
Avitia
completed $5 million Seed Round funding. Investors include
PacBridge Capital Partners (lead).
About
Avitia delivers advanced NGS-molecular testing solutions directly to laboratories via the company’s AI/ML platform. The company’s modular precision medicine technology equips cancer centers with cutting-edge NGS capabilities and network-wide insights. With Avitia’s automated platform, any lab can conduct liquid biopsy assays on-site — reducing testing time and cost while improving patient outcomes. With Avitia’s solutions available anywhere doctors treat patients, local oncologists are empowered to best serve their communities.
Startup
Sector:
AI
MedTech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
